ES287334A1 - Un procedimiento de preparación de compuestos esteroides 5(10)-deshidro - Google Patents

Un procedimiento de preparación de compuestos esteroides 5(10)-deshidro

Info

Publication number
ES287334A1
ES287334A1 ES287334A ES287334A ES287334A1 ES 287334 A1 ES287334 A1 ES 287334A1 ES 287334 A ES287334 A ES 287334A ES 287334 A ES287334 A ES 287334A ES 287334 A1 ES287334 A1 ES 287334A1
Authority
ES
Spain
Prior art keywords
translation
carbon atoms
machine
legally binding
google translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES287334A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of ES287334A1 publication Critical patent/ES287334A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
ES287334A 1962-04-25 1963-04-24 Un procedimiento de preparación de compuestos esteroides 5(10)-deshidro Expired ES287334A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR895563A FR1380415A (fr) 1962-04-25 1962-04-25 Procédé de préparation de stéroïdes à double liaison en position 5 (10)

Publications (1)

Publication Number Publication Date
ES287334A1 true ES287334A1 (es) 1963-07-16

Family

ID=8777621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES287334A Expired ES287334A1 (es) 1962-04-25 1963-04-24 Un procedimiento de preparación de compuestos esteroides 5(10)-deshidro

Country Status (7)

Country Link
AT (1) AT253696B (de)
BR (1) BR6348576D0 (de)
CH (1) CH414609A (de)
DK (1) DK105336C (de)
ES (1) ES287334A1 (de)
FR (2) FR1380415A (de)
GB (1) GB1015013A (de)

Also Published As

Publication number Publication date
FR2323M (fr) 1964-02-10
FR1380415A (fr) 1964-12-04
GB1015013A (en) 1965-12-31
CH414609A (fr) 1966-06-15
AT253696B (de) 1967-04-25
BR6348576D0 (pt) 1973-07-03
DK105336C (da) 1966-09-19

Similar Documents

Publication Publication Date Title
ES300814A1 (es) Un procedimiento para la prepación de compuestos esteroides
ES299652A1 (es) Un procedimiento para la preparación de compuestos esteroides
ES287334A1 (es) Un procedimiento de preparación de compuestos esteroides 5(10)-deshidro
ES334021A1 (es) Un procedimiento de preparacion de los 3-oxo 7alfa-metil estra-4,9-dienos.
ES319114A1 (es) Un procedimiento de preparacion de los 21-hidroxi esteroides de la serie del pregnano esterificados en la posicion 21.
GB1128787A (en) Processes for the preparation of unsaturated 19-nor-steroids
GB950899A (en) Improvements in or relating to steroidal alkyl ethers
GB1041089A (en) Androstane derivatives
ES325262A1 (es) Procedimiento para la produccion de esteroides.
GB1038349A (en) Androstane derivatives
ES393637A1 (es) Procedimiento de preparacion de esteroides.
GB965929A (en) Novel steroid compounds and their production
ES310875A1 (es) Un procedimiento de preparacion de nuevos esteroides nitrogenados.
ES319507A1 (es) Un metodo de producciën de preparaciones farmaceuticas
ES320857A1 (es) Un procedimiento para la produccion de derivados de fenantreno.
ES265558A1 (es) Procedimiento para la preparacion de derivados de 1-metil-estratieno
ES313421A1 (es) Un procedimiento de preparaciën de derivados esteroides trienicos
ES276247A1 (es) Procedimiento para la preparación de nuevos derivados de iminodibencilo
ES240717A1 (es) Un procedimiento para la preparaciën de nuevos compuestos esteroides
ES329370A1 (es) Un procedimiento de preparacion de 3-or2'-amino tiazolo - (5',4'-16,17) - estra 1,3,5 (10),16-tetraenos.
ES278247A1 (es) Procedimiento para preparar un metilendioxi-esteroide sustituído en 17-alfa, 21-(1'-alcoxi)-1'
ES301729A1 (es) Procedimiento para preparar compuestos esteroides
GB971049A (en) Novel cyclopentanophenanthrene compounds and a process for the production thereof
GB1001703A (en) 2-formyl-í¸-17ª‰-hydroxy-androstene compounds and process for their production
ES334803A1 (es) Un procedimiento de preparacion de los 3-oxo 13 beta-r 17 beta-ox 2-oxa 4,9,11-gonatrienos.